The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer

被引：11

作者：

Bemis D.L. ^{[1
]}

Capodice J.L. ^{[1
]}

Costello J.E. ^{[1
]}

Vorys G.C. ^{[1
]}

Katz A.E. ^{[1
]}

Buttyan R. ^{[1
]}

机构：

[1] Department of Urology, Columbia University, Irving-II, New York, NY 10032

来源：

Current Urology Reports | 2006年 / 7卷 / 3期

关键词：

Prostate Cancer; Curcumin; Resveratrol; Prostate Cancer Cell; Genistein;

D O I：

10.1007/s11934-006-0017-x

中图分类号：

学科分类号：

摘要：

Having a high probability of experiencing prostate cancer during their lifetime, men are increasingly seeking protection against this disease with the use of over-the-counter dietary supplements containing herbs, vitamins, or plant-derived biochemical agents. The use of these agents for prostate cancer prevention is driven by epidemiology supporting the idea that regional diets and consumption of specific dietary components (certain herbs, vitamins, isoflavones, and polyphenols) are associated with a lower risk for prostate cancer, in conjunction with basic research that is defining molecules within food substances that kill or suppress growth of cultured human prostate cancer cells. Moreover, there is a sense that these dietary agents lack side effects, although this assumption often is faulty. Unfortunately, at this time, there is insufficient clinical evidence to support the widespread use of these dietary supplements for chemoprevention of prostate cancer, although ongoing clinical trials of the most promising vitamins and minerals are approaching conclusion. Copyright © 2006 by Current Science Inc.

引用

页码：166 / 174

页数：8

共 91 条

[71]

Gupta S., Hastak K., Ahmad N., Et al., Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols, Proc Natl Acad Sci U S A, 98, pp. 10350-10355, (2001)

[72]

Roomi M.W., Ivanov V., Kalinovsky T., Et al., In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: Evaluation of tumor growth and immunohistochemistry, In Vivo, 19, pp. 179-183, (2005)

[73]

Adhami V.M., Siddiqui I.A., Ahmad N., Et al., Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer, Cancer Res, 64, pp. 8715-8722, (2004)

[74]

Choan E., Segal R., Jonker D., Et al., A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach, Urol Oncol, 23, pp. 108-113, (2005)

[75]

Jatoi A., Ellison N., Burch P.A., Et al., A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma, Cancer, 97, pp. 1442-1446, (2003)

[76]

Ratan H.L., Steward W.P., Gescher A.J., Mellon J.K., Resveratrol-a prostate cancer chemopreventive agent?, Urol Oncol, 7, pp. 223-227, (2002)

[77]

Hsieh T.C., Wu J.M., Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines, Exp Cell Res, 249, pp. 109-115, (1999)

[78]

Kim Y.A., Rhee S.H., Park K.Y., Choi Y.H., Antiproliferative effect of resveratrol in human prostate carcinoma cells, J Med Food, 6, pp. 273-280, (2003)

[79]

Narayanan B.A., Narayanan N.K., Re G.G., Nixon D.W., Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets, Int J Cancer, 104, pp. 204-212, (2003)

[80]

Lin H.Y., Shih A., Davis F.B., Et al., Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line, J Urol, 168, pp. 748-755, (2002)

← 1 2 3 4 5 6 7 8 9 10 →